Biology Avery Lecture

Terry Fry '88 

Professor of Pediatrics, Hematology and Immunology

Co-Director, Human Immunology and Immunotherapy Initiative and

Director of Cancer Immunotherapy

University of Colorado School of Medicine

Robert and Kathleen Clark Endowed Chair in Pediatric Cancer Therapeutics

Children’s Hospital Colorado | Center for Cancer and Blood Disorders

Dr. Fry was among the first scientists to investigate the potential to insert modified genes into a child’s own T-cells to target CD19, a surface protein found on nearly all cells affected by acute lymphoblastic leukemia (ALL). The first product using this technology, called chimeric antigen T-cell (CAR-T cells), was approved by the FDA for pediatric use in August 2017 and achieved an astonishing 80 percent remission rate in children with highly refractory leukemia resistant to all other therapies including conventional bone marrow transplant.

Tuesday, April 10 at 11:30am to 12:30pm

Ho Science Center, 101
1819 Oak Dr, Hamilton, NY 13346, USA

Topic

Academics, Natural Sciences Mathematics

Event Type

Lectures, colloquia, seminars, etc.

Group
Biology Department
Contact E-mail

rbeers@colgate.edu

Add to Personal calendar
Google Calendar iCal Outlook

Recent Activity